ATE218861T1 - Vasculäre hypertrophicsuppressor - Google Patents

Vasculäre hypertrophicsuppressor

Info

Publication number
ATE218861T1
ATE218861T1 AT94102790T AT94102790T ATE218861T1 AT E218861 T1 ATE218861 T1 AT E218861T1 AT 94102790 T AT94102790 T AT 94102790T AT 94102790 T AT94102790 T AT 94102790T AT E218861 T1 ATE218861 T1 AT E218861T1
Authority
AT
Austria
Prior art keywords
optionally substituted
ring
hetero
residue
suppressor
Prior art date
Application number
AT94102790T
Other languages
English (en)
Inventor
Kohei Nishikawa
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE218861T1 publication Critical patent/ATE218861T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/41841,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Vascular Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT94102790T 1993-02-25 1994-02-24 Vasculäre hypertrophicsuppressor ATE218861T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3663093 1993-02-25

Publications (1)

Publication Number Publication Date
ATE218861T1 true ATE218861T1 (de) 2002-06-15

Family

ID=12475158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94102790T ATE218861T1 (de) 1993-02-25 1994-02-24 Vasculäre hypertrophicsuppressor

Country Status (6)

Country Link
US (2) US5508297A (de)
EP (1) EP0612523B1 (de)
AT (1) ATE218861T1 (de)
CA (1) CA2115985A1 (de)
DE (1) DE69430766T2 (de)
ES (1) ES2173895T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19820151A1 (de) * 1998-05-06 1999-11-11 Hexal Ag Transdermales therapeutisches System zur Anwendung von Candesartan
EP1262180A4 (de) * 2000-02-18 2005-06-01 Takeda Pharmaceutical Tnf-alpha hemmer
US20030187038A1 (en) * 2000-08-25 2003-10-02 Yoshimi Imura Fibrinogen-lowering agents
US7546089B2 (en) * 2004-12-23 2009-06-09 Triquint Semiconductor, Inc. Switchable directional coupler for use with RF devices
WO2008123536A1 (en) * 2007-03-28 2008-10-16 Takeda Pharmaceutical Company Limited Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a ph control agent
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2016710A1 (en) * 1989-05-15 1990-11-15 Prasun K. Chakravarty Substituted benzimidazoles as angiotensin ii antagonists
EP0411507B1 (de) * 1989-08-02 1994-10-26 Takeda Chemical Industries, Ltd. Pyrazol-Derivate, Verfahren zu deren Herstellung und Anwendung
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
US5250554A (en) * 1989-10-24 1993-10-05 Takeda Chemical Industries, Ltd. Benzimidazole derivatives useful as angiotensin II inhibitors
EP0430300A3 (en) * 1989-12-01 1992-03-25 Takeda Chemical Industries, Ltd. Xanthine derivatives, their production and use
EP0434038A1 (de) * 1989-12-22 1991-06-26 Takeda Chemical Industries, Ltd. Kondensierte Imidazolderivate, ihre Herstellung und Verwendung
ATE169915T1 (de) * 1990-02-15 1998-09-15 Takeda Chemical Industries Ltd Pyrimidindionderivate, deren herstellung und verwendung
US5284661A (en) * 1990-02-22 1994-02-08 Takeda Chemical Industries, Ltd. Fused thiophene derivatives, their production and use
CA2037630C (en) * 1990-03-07 2001-07-03 Akira Morimoto Nitrogen-containing heterocylic compounds, their production and use
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5166143A (en) * 1990-05-31 1992-11-24 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing an ace inhibitor
DE69130192T2 (de) * 1990-06-08 1999-03-25 Hoechst Marion Roussel, Puteaux Benzimidazol-Derivate, Verfahren und Zwischenprodukte zu ihrer Herstellung, ihre Anwendung als Arzneimittel und diese enthaltende pharmazeutische Zusammensetzungen
AU636066B2 (en) * 1990-10-30 1993-04-08 Takeda Chemical Industries Ltd. Thienoimidazole derivatives, their production and use
GB9027200D0 (en) * 1990-12-14 1991-02-06 Smithkline Beecham Plc Medicaments
DE4225756A1 (de) * 1992-01-22 1994-03-10 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
TW274551B (de) * 1991-04-16 1996-04-21 Takeda Pharm Industry Co Ltd
US5210211A (en) * 1991-06-21 1993-05-11 Warner-Lambert Company 4-(1h-pyrrol-1-yl) imidazoles with angiotension ii antagonist activity
IL102183A (en) * 1991-06-27 1999-11-30 Takeda Chemical Industries Ltd Biphenyl substituted heterocyclic compounds their production and pharmaceutical compositions comprising them
DE69333489T2 (de) * 1992-09-14 2005-04-14 Takeda Chemical Industries, Ltd. Heterocyclische Verbindungen und ihre Verwendung als Angiotensin II Antagonisten
DE69330593T2 (de) * 1992-12-22 2002-06-27 Takeda Chemical Industries, Ltd. Heterocyclische Verbindungen mit Angiotensin-II-antagonistischer Wirkung und ihre Anwendung

Also Published As

Publication number Publication date
DE69430766T2 (de) 2003-02-06
DE69430766D1 (de) 2002-07-18
ES2173895T3 (es) 2002-11-01
US5736561A (en) 1998-04-07
US5508297A (en) 1996-04-16
EP0612523A1 (de) 1994-08-31
CA2115985A1 (en) 1994-08-26
EP0612523B1 (de) 2002-06-12

Similar Documents

Publication Publication Date Title
HUP0002476A2 (hu) Aminvegyületek, előállításuk és alkalmazásuk
ATE327230T1 (de) Piperidinverbindungen und diese enthaltenden medikamente
PT1063228E (pt) Derivados de cicloalcenos processo para a sua preparacao e utilizacao
DE69407409D1 (de) Azolylamin-derivat
TW256832B (de)
FI944417A0 (fi) Atsoliyhdisteet, niiden valmistus ja käyttö
EP0671390A3 (de) Antithrombotische Mittel
EP0293771A3 (de) Cephalosporinverbindungen und sie enthaltende pharmazeutische Präparate
NO972887L (no) Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel
ATE218861T1 (de) Vasculäre hypertrophicsuppressor
ATE203020T1 (de) Schwefel enthaltende heterocyclische verbindungen
EP0648760A3 (de) Triazin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung.
EP0712398A1 (de) Benzopyrane und diese enthaltende pharmazeutische zusammenstellungen
AP2000002008A0 (en) Tetrahydroquinoline derivatives as glycine antagonists.
DE69423529D1 (de) Arzneizusammensetzungen enthaltend Argatrobananaloge
MY108849A (en) Novel compound
ATE176906T1 (de) Benzolactam-derivate
TW259785B (en) Chemical compounds
ATE168679T1 (de) Neue tetracyclische verbindungen
DE69014930D1 (de) Aralkylamin-Verbindungen.
DE69016266D1 (de) Aminoketonverbindungen.
GB9104833D0 (en) Heterocyclic compounds
TH18165A (th) สารยับยั้งการเกิดคีโมแทกซิของอีโอซีโนฟีล
TH14340A (th) กรรมวิธีสำหรับเตรียมสารประกอบคาร์แบเพเนมและเพเนมและสารประกอบชนิดใหม่ที่เกี่ยวข้องในกรรมวิธีดังกล่าว

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties